XM无法为美国居民提供服务。
P
P

Pfizer

技术摘要

指标价值趋势
指标价值趋势
指标价值趋势
指标S3S2S1PR1R2R3

市场新闻

US FDA pauses Novavax's trial of combo flu shot on safety concerns

UPDATE 4-US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns Adds analyst comment in paragraphs 7 and 11; Sanofi's response in paragraph 10 By Bhanvi Satija Oct 16 (Reuters) - The U.S. Food and Drug Administration has put on hold a trial of Novavax's NVAX.O COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage, the company said on Wednesday.
P
S

An Van Gerven Is Appointed President Of Pfizer Canada

BRIEF-An Van Gerven Is Appointed President Of Pfizer Canada Oct 15 (Reuters) - Pfizer Canada: AN VAN GERVEN IS APPOINTED PRESIDENT OF PFIZER CANADA Source text for Eikon: ID:nCNW9TK6Ba Further company coverage: []
P

GSK sues Moderna for US patent infringement over COVID, RSV vaccines

UPDATE 2-GSK sues Moderna for US patent infringement over COVID, RSV vaccines Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna Adds information about RSV vaccine claims in paragraphs 1 and 6 By Blake Brittain Oct 15 (Reuters) - British drugmaker GlaxoSmithKline GSK.L sued Moderna MRNA.O in U.S.
G
N
P

Pfizer taps Vanguard veteran for board amid fight with Starboard

Pfizer taps Vanguard veteran for board amid fight with Starboard By Svea Herbst-Bayliss NEW YORK, Oct 15 (Reuters) - Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value. Mortimer "Tim" Buckley served as Vanguard's chairman and chief executive until this year when he announced his retirement.
P

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines Oct 15 (Reuters) - GlaxoSmithKline GLAX.NS sued Moderna MRNA.O in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax. The lawsuit said Moderna's lipid nanoparticles for transporting mRNA into the human body infringe several GSK patents covering similar innovations.
P

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明